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Abstract 27
Background: The incidence of dementia and cognitive decline is increasing with no therapy or 28 cure. One of the reasons treatment remains elusive is because there are various pathologies 29 that contribute to age-related cognitive decline. Specifically, with Alzheimer's disease, targeting 30 to reduce amyloid beta plaques and phosphorylated tau aggregates in clinical trials has not 31 yielded results to slow symptomology, suggesting a new approach is needed. Interestingly, 32 exercise has been proposed as a potential therapeutic intervention to improve brain health and 33 reduce the risk for dementia, however the benefits throughout aging are not well understood. 34
Results: To better understand the effects of exercise, we preformed transcriptional profiling on 35 young (1-2 months) and midlife (12 months) C57BL/6J (B6) male mice after 12 weeks of 36 voluntary running. Data was compared to age-matched sedentary controls. Interestingly, the 37 midlife running group naturally broke into two cohorts based on distance ran -either running a 38 lot and more intensely (high runners) or running less and less intensely (low runners). Midlife 39 high runners had lower LDL cholesterol as well as lower adiposity (%fat) compared to 40 sedentary, than midlife low runners compared to sedentary suggesting more intense running 41 lowered systemic markers of risk for age-related diseases including dementias. Differential gene 42 analysis of transcriptional profiles generated from the cortex and hippocampus showed 43 thousands of differentially expressed (DE) genes when comparing young runners to sedentary 44 controls. However, only a few hundred genes were DE comparing either midlife high runners or 45 midlife low runners to midlife sedentary controls. This indicates that, in our study, the effects of 46 running are reduced through aging. Gene set enrichment analyses identified enrichment of 47 decline and dementias. Obesity and physical inactivity increase risk for cognitive decline and 103 dementia, suggesting that interventions such as diet and exercise can mitigate risk (9). Exercise 104 has positive effects, not just improving systemic health, but also cerebral health through 105 increases in cerebral plasticity, neurogenesis, as well as hippocampal and cortical volume (10, 106 11). For example, exercise earlier in life correlated with reduced cognitive impairment with age 107 (12). The cerebral benefits of exercise may arise through the induction of brain derived 108 neurotropic factor (BDNF), which triggers neuronal proliferation in the dentate gyrus (13). A 109 recent study has also explored the use of running, as well as an AAV-based gene therapy to 110 increase neuronal proliferation and survival, in a mouse model of AD (14). Viral-induced 111 neurogenesis alone did not benefit cognition as well as running did, suggesting that running also 112 promotes non-neuronal changes that improve cognition. Therefore, the full spectrum of 113 processes by which running promotes brain health and reduces risk for dementias remains 114 unclear. Furthermore, given that many such studies are performed in young mice, it remains 115 unknown whether the beneficial effects of running persist through multiple life stages. 116 Here, we chose an unbiased transcriptional profiling approach to better understand the 117 effects of running on overall brain health. To date, an extensive evaluation of the transcriptome 118 of the brain in response to running across ages has not been assessed. RNA sequencing was 119 performed on the cortex and hippocampus from young and middle aged (midlife) C57BL/6J (B6) 120 male mice that were provided running wheels for 12 weeks. Transcriptional profiles were 121 compared to aged-matched sedentary controls. Within the midlife running cohort, half the mice 122 ran markedly faster and farther (high runners) than the other half (low runners). This provided 123 natural variation in our midlife running dataset and allowed us to also interrogate how the 124 intensity of running impacted systemic bodily health as well as transcriptional profiles in the 125 brain. The young cohort did not exhibit such variation in their voluntary exercise. 
Results

214
Voluntary running distances at midlife showed a bimodal distribution 215
To understand the molecular changes in the brain in response to voluntary running, 216 running wheels were provided to young (1-2 month old, mo) and midlife (12 mo) B6 male mice 217 for 12 weeks. Age-matched sedentary controls had no access to a running wheel (Fig. 1A) . To 218 quantify running, wheel rotations per minute were assessed overnight, when mice are most 219 active, for at least five nights during the last week of the experiment. Although there was some 220 variation between average wheel rotations per night in the young cohort, five of six mice 221 averaged over 10,000 rotations per night. Of the 12 midlife running mice however, half averaged 222 fewer than 10,000 rotations per night, deemed 'Low Runners', and half averaged greater than 223 10,000 rotations per night, deemed 'High Runners' (Fig. 1B) . This was not due to dominance in 224 group housing (Table S1 ). High runners ran a similar distance (on average, greater than 10,000 225 rotations per night) to young runners. Additionally, midlife high runners spent more time running 226 compared to midlife low runners (Fig. 1C) . High runners also were quantified to have run at 100 227 rotations per minute, while the low runners did not show this ability. Young sedentary mice 228 gained more weight over the course of the experiment than young running mice (Fig. 1E) . 229
Similarly, in the midlife running cohort, high runners tended to weigh less throughout the 230 experiment, although not significantly at the conclusion of the 12 weeks (Fig. 1F) . To better 231 understand body composition in the midlife cohort, mice were subjected to NMR a week beforeharvest to assess fat and lean mass percentages. Midlife high runners showed a significant 233 decrease in fat mass (g) reflected by a corresponding decrease in adiposity (%fat) (Fig. S1A,  234 S1B, S1D). Lean muscle mass was not different among the groups but the midlife high running 235 cohort had a higher percent lean muscle mass compared to low running and sedentary cohorts, 236 presumably due to the lower body weight of the high runners (Fig. S1C, S1E ). This indicates 237 that weight loss of the high run cohort was primarily fat mass. 238
To assess whether running during midlife altered metabolic indicators of health in the 239 blood, we measured cholesterol composition, non-fasted glucose, triglycerides, and non-240 essential fatty acids (NEFA) levels. Total cholesterol was significantly reduced in young runners 241 compared to age-matched sedentary controls ( Fig. 2A) . Midlife high runners also showed a 242 significantly lower total cholesterol profile compared to midlife sedentary controls, which could 243 be attributed to the decrease in LDL cholesterol ( Fig. 2A-2C ). HDL cholesterol remained 244 unchanged with running (Fig. 2C) . Non-fasted glucose levels were not significantly different, 245 although there was trend towards lower blood glucose in running compared to sedentary mice 246 at both ages (Fig. 2D) . Triglycerides and non-essential fatty acids (NEFA) were reduced by 247 running at a young age, but this effect was not seen in the midlife cohort (Fig. 2E, 2F) . Taken 248 together, there was a significant shift towards a healthier body composition in midlife high 249 runners compared to low runners. Further, systemic health benefits such as levels of total 250 cholesterol, including LDL, can be altered at midlife due to more intense running. 251
252
Young running affects transcriptional signatures more robustly than midlife running 253
To assess transcriptional changes in the brain after running at two different ages, RNA-254 seq was performed on hippocampus and cortex -vulnerable regions in age-related cognitive 255 decline and dementia (Fig. S2, S3 ). Differentially expressed (DE) genes (FDR <0.05) were 256 identified by comparing (i) young running to young sedentary, (ii) midlife high runners to midlife 257 sedentary, and (iii) midlife low runners compared to midlife sedentary (Table S2- Next, we sought to identify which pathways and genes were significantly altered by 273 running at a young age, but showed no difference at midlife. We first analyzed transcriptional 274 data through Ingenuity Pathway Analysis (IPA) canonical pathway analysis. DE genes 275 comparing young runners to young sedentary controls were enriched for canonical pathway 276 terms 'Hepatic Fibrosis', 'GP6 Signaling', and 'Circadian Rhythm Signaling' in the cortex and 277 hippocampus. (Fig. 3C, 3H ). These pathways were not enriched in the midlife data. 'Hepatic 278
Fibrosis' and 'GP6 Signaling Pathway' terms contain extracellular matrix (ECM)-related genes, 279 such as collagens and laminins. KEGG pathway analysis further identified 'ECM-receptor 280
Interaction' and 'Focal Adhesion' in the cortex and hippocampus, which substantiated the 281 significant changes to the ECM (Fig. 3D, 3I ). There were no KEGG terms enriched in either the 282 cortex or hippocampus for the midlife low runners. Only the KEGG pathway 'Malaria' was Col5a1 (FDR= 9.03e-8,FC= -1.75), and Lamc2 (FDR= 6.85e-8,FC= -2.07)) which were all 290 downregulated. This suggests that more intense running at midlife can influence ECM-related 291 genes, but potentially not in a positive way. 292 GO terms are a way of categorizing DE genes into functional biological groups. GO term 293 analysis of the DE genes from the cortex and hippocampus data from young runners showed 294 enrichment for 'ECM Organization' and 'Cell Adhesion' (Fig. 3E, 3J) . Interestingly, vascular 295 remodeling-related terms were significantly enriched in the cortex of young runners, including 296 terms such as 'blood vessel remodeling', 'ECM Organization', 'Angiogenesis', and 'Cell 297
Adhesion' (Fig. 3E) . None of these terms were enriched in the midlife data, irrespective of 298 distance ran. However, one GO term, 'Cellular Oxidant Detoxification', which comprised mainly 299 hemoglobin component genes, was enriched in both low and high runners in the hippocampus 300 but only in the high runners of the cortex at midlife. These data suggest there is an overall 301 change in ECM composition or organization due to running at a young age that is not reflected 302 to the same degree at midlife. (Fig. 3) . 303 304
Running upregulates genes related to vascular remodeling in young but not midlife mice 305
IPA revealed 'Hepatic Fibrosis' and 'GP6 Signaling' as significantly enriched canonical 306 pathways in both the cortex and the hippocampus (Fig. 3) . These pathways contain manySignaling' pathway were upregulated in the young runners in both the cortex and hippocampus 310 but were not DE in either midlife high or low runners (Fig. 4B-F) . 311
GO term analysis identified enrichment of 'ECM organization', 'Blood Vessel 312
Remodeling' and 'Angiogenesis' in the cortex (Fig. 5A) . These terms were significantly enriched 313 in young mice but not in midlife mice. Of these vascular terms, 'Angiogenesis' contained 32 314 genes (26 upregulated, 6 downregulated) (Fig. 5A, B (Fig. 5C-D) . 321
322
Running activates genes in multiple cerebrovascular-related cell types 323
Finally, we determined whether specific cell types were more dramatically affected by 324 young but not midlife running. This might provide insight into which cell type(s) are no longer 325 responding to running in midlife mice. A sample of basement membrane and angiogenesis 326 genes DE in young, but not midlife, running datasets were cross referenced to two cell-type 327 specific datasets -the Brain RNA seq and a single cell RNA-seq dataset focused on 328 cerebrovascular associated cells (20) (21). First, we evaluated Col4 and laminin genes that 329 were DE in young runners. As expected, the majority of the genes were expressed by 330 cerebrovascular-related cells such as astrocytes and endothelial cells and not other cells in 331 brain such as neurons, oligodendrocytes and microglia (Table S9) (Fig. 6) . Second, we assessed cell type specific 336 expression of angiogenesis genes. Upstream components of the angiogenesis pathway were 337 mainly expressed by astrocytes, including Mmp14 and Vegfa (Fig. 7A, B) .
Here, we assessed B6 male mice at two ages, young and midlife, to better understand 344 the effects of running on the aging brain. Our data suggest that intervention of running may not 345 be as beneficial to the cerebrovasculature in midlife. While systemic health (lipid profile, body 346 composition) is improved by running at midlife, the cerebrovasculature is not as responsive. 347
Therapies or interventions during midlife may require different approaches than preventative 348 measures in young, more responsive individuals. In this study, half the midlife cohort (high 349 runners) ran as much as the young cohort, whereas the other half ran far less (low runners, Fig.  350   1) . Interestingly, this did not drastically affect the transcriptional profiles (Fig. 3) and improve cognition (14, 22-24). However, the brain during development and early adult life is 357 considered more plastic than in later life, which incites therapies that will not properly translate 358 to aged trials (2) (25). 359
We took an unbiased approach to identify transcriptional changes in two vulnerable brainfrom running was to the cerebrovasculature. Particularly, we highlight genes involved in 362 basement membrane composition (particularly collagens and laminins) that are upregulated in 363 young mice due to running that were not affected by running at midlife. Similarly, genes in the 364 angiogenesis pathway (e.g. Mmp14, Vegfa, Kdr, Flt1, Dll4, and Notch1) showed induction by 365 running in young but not midlife mice (19). These transcriptional data suggest that the benefits 366 of exercise to the cerebrovasculature declines with age, increasing the need for a greater 367 understanding of midlife exercise as an intervention for cognitive decline and dementia (26). 368
Previous studies have focused on the neuroprotective benefits of exercise. In Choi et al., 369 of the 5XFAD mice (a model relevant to AD) that were exercised, half were categorized as 370
showing increased neurogenesis while the other half did not show this effect, potentially due to 371 the amount run (14). Additionally, it was shown that viral-induced neurogenesis was not enough 372 to rescue cognitive decline, while exercise-induced neurogenesis was able to sufficiently 373 improve cognitive results (14). This finding suggests that running is providing additional benefits 374 to substantiate neurogenesis mediated improvements in cognition. Based on the results of our 375 study, we predict that in Choi et al. there were running-induced improvements to the 376 cerebrovasculature which would provide better clearance of amyloid and better maintenance of 377 neuronal health resulting in improved cognition (14). It is known that the development of the 378 neuronal and vasculature systems is strongly linked, with growth occurring simultaneously 379 because neurons require vascular support for oxygen and nutrients. This further supports the 380 need for cerebrovascular improvement to accompany adult therapy-induced neurogenesis (27). 381
If neurogenesis and angiogenesis become uncoupled, this may cause stress to neurons, 382 reduced cerebral blood flow, and a disruption to neurovascular coupling. Therefore, when 383 considering midlife interventions to cognitive decline and dementia it is important to consider 384 both neuronal and cerebrovascular health. 385
A limitation of our study is that we used healthy wild-type male mice to assess the 386 effects of exercise at two different ages. In our study, the effects of exercise were greater inyoung compared to midlife male mice. It is possible that exercise at midlife would be beneficial 388 in female mice and also in mice that are predisposed to vascular damage and dementia through 389 genetic or environmental risk factors. Due to the increasing recognition of a vascular 390 contribution to dementia symptomology, it would be pertinent to know if running alleviates these 391 effects of vascular risk in genetically predisposed mice at different ages. For example, the ε 4 392 allele of apolipoprotein E (APOE ε 4 ), the greatest risk factor for late-onset AD and Vascular 393 Dementia, shows early cerebrovascular decline in both mice and humans (28) (29). This is 394 proposed to be due to a lack of binding of APOE ε 4 to the low density lipoprotein receptor related 395 protein 1 (LRP1) leading to an increase in MMP9 and a breakdown of basement membrane 396 proteins and endothelial cell tight junctions (28). Therefore, when evaluating running as a 397 potential intervention, it is imperative to understand whether benefits will be seen across 398 multiple dementia risk genotypes. Although these experiments are challenging to perform in 399 human populations, they can be readily performed in mouse models. 400
Due to the heterogeneity of dementia pathology, it is possible that the typical approach 401 to treating dementias, is too narrow in scope, only able to alleviate the burden of a small subset 402 of dementia cases. Only recently has the American Heart Association acknowledged the 403 prevalence of Vascular Contributions to Cognitive Impairment and Dementia (VCID), explaining 404 that cerebral infarcts are frequent and common with age, including in patients with diagnosed 405 with AD (30). We hypothesize that exercise is key in identifying new pathways, specifically 406 those related to cerebrovascular health, that may help a broader population of dementia 407 patients. In summary, our research and others show that exercise benefits cerebral health by 408 improving multiple systems including the cerebrovasculature. However, the benefits of exercise 409 appear to decline with age, further supporting that combinatorial approaches are required to COL3A1  COL26A1  COL1A1  COL23A1  COL20A1  COL5A2  COL6A3  COL27A1  COL5A1  LAMC3  LAMA4  COL24A1  COL11A1  PKCOE¥  COL15A1  COL8A1  KLF12  COL7A1  COL4A2  LAMA5  LAMA2  COL4A1  COL11A2  LAMB2  SCHIP1  - 
